You have to account for the merger as the sale of your Celgene stock on the date of the merger. The proceeds of the sale is equal to the cash you received and the value of the BMS stock on the date of the merger.
The cost basis of your BMS stock is the value on the merger date.
**Say "Thanks" by clicking the thumb icon in a post
**Mark the post that answers your question by clicking on "Mark as Best Answer"
